COMPASS Pathways Ownership | Who Owns COMPASS Pathways?
COMPASS Pathways Ownership Summary
COMPASS Pathways is owned by 58.20% institutional investors, 13.64% insiders, and 28.16% retail investors. Tcg crossover management is the largest institutional shareholder, holding 5.64% of CMPS shares. ARK Genomic Revolution is the top mutual fund, with 1.92% of its assets in COMPASS Pathways shares.
CMPS Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | COMPASS Pathways | 58.20% | 13.64% | 28.16% |
Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
Industry | Medical Care Facilities Stocks | 56.17% | 12.26% | 31.58% |
Idea | Psychedelic Stocks List | 41.70% | 15.31% | 42.99% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Tcg crossover management | 3.86M | 5.64% | $14.58M |
Millennium management | 3.41M | 4.99% | $12.90M |
Rtw investments, lp | 3.10M | 4.53% | $11.71M |
Ark investment management | 1.74M | 2.54% | $6.56M |
Vivo capital | 1.61M | 2.35% | $6.08M |
Gmt capital | 1.55M | 2.26% | $5.85M |
Nantahala capital management | 1.00M | 1.46% | $3.78M |
Tang capital management | 1.00M | 1.46% | $3.78M |
Aisling capital management lp | 964.50K | 1.41% | $3.65M |
Rosalind advisors | 707.63K | 1.03% | $2.67M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Founders fund vii management | 278.88K | 100.00% | $1.05M |
Tcg crossover management | 3.86M | 1.43% | $14.58M |
Rosalind advisors | 707.63K | 1.37% | $2.67M |
Aisling capital management lp | 964.50K | 1.29% | $3.65M |
Vivo capital | 1.61M | 0.68% | $6.08M |
Brown university | 214.20K | 0.35% | $809.68K |
Gmt capital | 1.55M | 0.29% | $5.85M |
Tang capital management | 1.00M | 0.25% | $3.78M |
Dafna capital management | 243.21K | 0.23% | $919.33K |
Rtw investments, lp | 3.10M | 0.18% | $11.71M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Rtw investments, lp | 3.10M | 0.18% | 3.10M |
Tang capital management | 1.00M | 0.25% | 1.00M |
Nantahala capital management | 1.00M | 0.16% | 800.00K |
Balyasny asset management | 650.28K | 0.00% | 650.28K |
Acadian asset management | 169.48K | 0.00% | 169.48K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Altium capital management lp | - | - | -1.42M |
Paradigm biocapital advisors lp | - | - | -1.16M |
Logos global management lp | - | - | -1.16M |
Sio capital management | - | - | -914.64K |
Affinity asset advisors | - | - | -850.51K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Rtw investments, lp | 3.10M | 0.18% | 3.10M | $11.71M |
Tang capital management | 1.00M | 0.25% | 1.00M | $3.78M |
Balyasny asset management | 650.28K | 0.00% | 650.28K | $2.46M |
Acadian asset management | 169.48K | 0.00% | 169.48K | $638.00K |
Blue owl capital lp | 161.24K | 0.14% | 161.24K | $609.48K |
Sold Out
Holder | Change |
---|---|
American capital advisory | -5.00 |
Eversource wealth advisors | -8.00 |
Ifp advisors | -10.00 |
Corecap advisors | -10.00 |
Nelson, van denburg & campbell wealth management group | -15.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 142 | 5.19% | 51,907,706 | 67.77% | 58 | 2.84% | 64 | 8.47% | 26 | - |
Dec 31, 2024 | 114 | -17.99% | 18,014,918 | -45.03% | 26 | 1.15% | 52 | - | 21 | -19.23% |
Sep 30, 2024 | 137 | 4.58% | 32,772,645 | 15.26% | 47 | 2.77% | 52 | - | 26 | 36.84% |
Jun 30, 2024 | 130 | 5.69% | 28,432,133 | 3.56% | 44 | 2.25% | 51 | 10.87% | 19 | -26.92% |
Mar 31, 2024 | 123 | -8.21% | 27,455,455 | 19.85% | 44 | 2.08% | 46 | -14.81% | 26 | -7.14% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
ARK Genomic Revolution | 1.78M | 1.92% | 61.27K |
ARK Genomic Revolution ETF | 1.65M | 1.76% | - |
Nikko Gbl All Biological Genome Eq MF | 316.75K | 0.46% | -67.45K |
iShares Biotechnology ETF | 375.34K | 0.40% | -4.91K |
BIT Biotech Opportunities S | 242.97K | 0.26% | - |
Putnam Sustainable Future A | 162.90K | 0.24% | - |
AdvisorShares Psychedelics ETF | 168.54K | 0.18% | - |
Putnam Sustainable Future ETF | 120.11K | 0.18% | 6.46K |
AZ Fd1 AZ Allc Tr A-AZ C | 150.28K | 0.16% | 273.00 |
10XDNA - Disruptive Technologies - I-II | 132.86K | 0.14% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Oct 24, 2024 | Malievskaia Ekaterina | - | Sell | - |
Oct 24, 2024 | Malievskaia Ekaterina | - | Sell | - |
Oct 24, 2024 | Goldsmith George Jay | - | Sell | - |
Oct 24, 2024 | Goldsmith George Jay | - | Sell | - |
Sep 26, 2024 | ATAI Life Sciences N.V. | - | Sell | $16.09M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | - |
2024 Q4 | - | 4 |
2024 Q3 | - | 1 |
2024 Q2 | - | 28 |
2024 Q1 | - | 44 |
CMPS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools